Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GEMSP: a new therapeutic approach to multiple sclerosis.
Geffard M, Duleu S, Bessede A, Vigier V, Bodet D, Mangas A, Covenas R. Geffard M, et al. Among authors: bessede a. Cent Nerv Syst Agents Med Chem. 2012 Sep;12(3):173-81. doi: 10.2174/187152412802430110. Cent Nerv Syst Agents Med Chem. 2012. PMID: 22533511 Review.
Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.
Puccetti P, Fallarino F, Italiano A, Soubeyran I, MacGrogan G, Debled M, Velasco V, Bodet D, Eimer S, Veldhoen M, Prendergast GC, Platten M, Bessede A, Guillemin GJ. Puccetti P, et al. Among authors: bessede a. PLoS One. 2015 Apr 16;10(4):e0122046. doi: 10.1371/journal.pone.0122046. eCollection 2015. PLoS One. 2015. PMID: 25881064 Free PMC article.
IDO Targeting in Sarcoma: Biological and Clinical Implications.
Nafia I, Toulmonde M, Bortolotto D, Chaibi A, Bodet D, Rey C, Velasco V, Larmonier CB, Cerf L, Adam J, Le Loarer F, Savina A, Bessede A, Italiano A. Nafia I, et al. Among authors: bessede a. Front Immunol. 2020 Mar 5;11:274. doi: 10.3389/fimmu.2020.00274. eCollection 2020. Front Immunol. 2020. PMID: 32194552 Free PMC article.
Aryl hydrocarbon receptor control of a disease tolerance defence pathway.
Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, Bianchi R, Lanz TV, Platten M, Della Fazia MA, Piobbico D, Zelante T, Funakoshi H, Nakamura T, Gilot D, Denison MS, Guillemin GJ, DuHadaway JB, Prendergast GC, Metz R, Geffard M, Boon L, Pirro M, Iorio A, Veyret B, Romani L, Grohmann U, Fallarino F, Puccetti P. Bessede A, et al. Nature. 2014 Jul 10;511(7508):184-90. doi: 10.1038/nature13323. Nature. 2014. PMID: 24930766 Free PMC article.
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors.
Peyraud F, Guégan JP, Bodet D, Nafia I, Fontan L, Auzanneau C, Cousin S, Roubaud G, Cabart M, Chomy F, Le Loarer F, Chaput N, Danlos FX, Planchard D, Even C, Khettab M, Tselikas L, Besse B, Barlesi F, Soria JC, Marabelle A, Bessede A, Italiano A. Peyraud F, et al. Among authors: bessede a. Ann Oncol. 2022 Oct;33(10):1041-1051. doi: 10.1016/j.annonc.2022.07.001. Epub 2022 Jul 16. Ann Oncol. 2022. PMID: 35850444 Free article. Clinical Trial.
HIPK1 drives p53 activation to limit colorectal cancer cell growth.
Rey C, Soubeyran I, Mahouche I, Pedeboscq S, Bessede A, Ichas F, De Giorgi F, Lartigue L. Rey C, et al. Among authors: bessede a. Cell Cycle. 2013 Jun 15;12(12):1879-91. doi: 10.4161/cc.24927. Epub 2013 May 15. Cell Cycle. 2013. PMID: 23676219 Free PMC article.
51 results